Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2007 1
2008 5
2009 1
2011 3
2012 2
2013 3
2014 4
2015 5
2016 12
2017 18
2018 15
2019 22
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Results by year
Filters applied: . Clear all
Page 1
The emerging role of the piRNA/piwi complex in cancer.
Liu Y, Dou M, Song X, Dong Y, Liu S, Liu H, Tao J, Li W, Yin X, Xu W. Liu Y, et al. Among authors: Liu S, Liu H. Mol Cancer. 2019 Aug 9;18(1):123. doi: 10.1186/s12943-019-1052-9. Mol Cancer. 2019. PMID: 31399034 Free PMC article. Review.
An injectable nanoparticle generator enhances delivery of cancer therapeutics.
Xu R, Zhang G, Mai J, Deng X, Segura-Ibarra V, Wu S, Shen J, Liu H, Hu Z, Chen L, Huang Y, Koay E, Huang Y, Liu J, Ensor JE, Blanco E, Liu X, Ferrari M, Shen H. Xu R, et al. Among authors: Liu H, Liu J, Liu X. Nat Biotechnol. 2016 Apr;34(4):414-8. doi: 10.1038/nbt.3506. Epub 2016 Mar 14. Nat Biotechnol. 2016. PMID: 26974511 Free PMC article.
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma.
Yan L, Ding B, Liu H, Zhang Y, Zeng J, Hu J, Yao W, Yu G, An R, Chen Z, Ye Z, Xing J, Xiao K, Wu L, Xu H. Yan L, et al. Among authors: Liu H. Theranostics. 2019 Oct 22;9(26):8377-8391. doi: 10.7150/thno.37628. eCollection 2019. Theranostics. 2019. PMID: 31754403 Free PMC article.
Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis.
Chen Z, Yuan P, Sun X, Tang K, Liu H, Han S, Ye T, Liu X, Yang X, Zeng J, Yan L, Xing J, Xiao K, Ye Z, Xu H. Chen Z, et al. Among authors: Liu H, Liu X. Am J Physiol Renal Physiol. 2019 Jul 1;317(1):F137-F151. doi: 10.1152/ajprenal.00047.2019. Epub 2019 May 15. Am J Physiol Renal Physiol. 2019. PMID: 31091119
The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy.
Li H, Wang Z, Zhang Y, Sun G, Ding B, Yan L, Liu H, Guan W, Hu Z, Wang S, Cheng F, Xu H, Zhang X, Ye Z. Li H, et al. Among authors: Liu H. J Cancer. 2019 Jun 2;10(14):3102-3111. doi: 10.7150/jca.30384. eCollection 2019. J Cancer. 2019. PMID: 31289580 Free PMC article.
90 results
Jump to page
Feedback